Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis

BACKGROUND: Linezolid has been prioritized for treating multidrug-resistant tuberculosis (MDR TB), but toxicity limits its use. We report treatment outcomes for MDR TB patients in California who received standard-dose linezolid vs those who switched to low-dose. METHODS: We include culture-positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Mase, Anjeli, Lowenthal, Phil, True, Lisa, Henry, Leslie, Barry, Pennan, Flood, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801093/
https://www.ncbi.nlm.nih.gov/pubmed/36601556
http://dx.doi.org/10.1093/ofid/ofac500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801093/
https://www.ncbi.nlm.nih.gov/pubmed/36601556
http://dx.doi.org/10.1093/ofid/ofac500

Ejemplares similares